Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at Week 24

BACKGROUND: The aims of this study were to compare results from a Taiwanese sub-study of the GLOBE 2303 telbivudine study and evaluate the HBV DNA kinetics. METHODS: Forty-one Taiwanese patients were treated for an additional 2 years with telbivudine. Efficacy endpoints were the same as the GLOBE st...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chao Wei, Chao, You Chen, Lee, Chuan Mo, Chang, Ting Tsung, Chen, Yi Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563525/
https://www.ncbi.nlm.nih.gov/pubmed/23234302
http://dx.doi.org/10.1186/1471-230X-12-178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563525/
https://www.ncbi.nlm.nih.gov/pubmed/23234302
http://dx.doi.org/10.1186/1471-230X-12-178

Ejemplares similares